Day: November 9, 2020

Mueller Water Products Reports 2020 Fourth Quarter and Fiscal Year Results

Achieved net sales of $265.3 million in Quarter, $964.1 million in Fiscal YearEarned Net Income per Diluted Share of $0.17 in Quarter, $0.45 in Fiscal YearDelivered Adjusted Net Income per Diluted Share of $0.17 in Quarter, $0.52 in Fiscal YearATLANTA, Nov. 09, 2020 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) announced today that for its fiscal 2020 fourth quarter ended September 30, 2020 net sales were $265.3 million and net income was $26.7 million.In the 2020 fourth quarter, the Company:Achieved net sales of $265.3 million, a decrease of 0.6 percent as compared with $266.9 million in the prior year quarter.Generated operating income of $40.7 million as compared with $39.0 million in the prior year quarter. Adjusted operating income was $41.8 million as compared with $42.6 million in the prior year quarter.Reported...

Continue reading

FINTECH ACQUISITION CORP. IV CLASS A COMMON SHARES AND WARRANTS TO COMMENCE TRADING SEPARATELY ON NOVEMBER 13, 2020

PHILADELPHIA, PA, Nov. 09, 2020 (GLOBE NEWSWIRE) — FinTech Acquisition Corp. IV (NASDAQ: FTIVU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that the holders of the Company’s units may elect to separately trade the Class A common shares and warrants underlying the units commencing on November 13, 2020. Those units not separated will continue to trade on the NASDAQ Capital Market under the symbol “FTIVU” and the Class A common shares and warrants are expected to trade under the symbols “FTIV” and “FTIVW”, respectively.A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission on September 24, 2020. This press release shall not constitute an offer to sell or the solicitation...

Continue reading

RCM Technologies, Inc. Announces Third Quarter Results

PENNSAUKEN, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care and information technology services, today announced financial results for the thirteen and thirty-nine week periods ended September 26, 2020.RCM Technologies reported revenue of $31.6 million for the thirteen week period ended September 26, 2020 (the current period), a 21.6% decrease as compared to $40.3 million for the thirteen week period ended September 28, 2019 (the comparable prior year period). Gross profit was $8.8 million for the current period, a 16.9% decrease as compared to $10.6 million for the comparable prior...

Continue reading

Atlas Technical Consultants, Inc. Announces Amendment to Registration Statement for its Exchange Offer and Consent Solicitation Relating to its Warrants

AUSTIN, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (NASDAQ: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, environmental and consulting services, today announced that it has filed an amendment (the “Amendment”) to its Registration Statement originally filed with the Securities and Exchange Commission (the “SEC”) on October 19, 2020, registering shares of Class A common stock, par value $0.0001 (the “Class A common stock”) of Atlas issuable as part of the Company’s previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding public warrants and private placement warrants (collectively, the “warrants”) to purchase shares of Class A common stock. Atlas filed the Amendment in order...

Continue reading

Upwork to Present at Upcoming Investor Conferences

SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent, as measured by gross services volume (“GSV”), today announced that President and CEO, Hayden Brown, and Chief Financial Officer, Jeff McCombs, will participate in the following virtual investor conferences:RBC Capital Markets 2020 Global Technology, Internet, Media, and Telecommunications Virtual ConferenceNovember 18, 2020 at 11:00a.m. PT/2:00p.m. ETCredit Suisse 24th Annual Technology ConferenceDecember 1, 2020 at 8:30a.m. PT/11:30a.m. ETChief Financial Officer, Jeff McCombs, will participate in the following virtual investor conference:The Road Ahead, Preparation for 2021: MKM Partners Virtual ConferenceDecember 15, 2020 at 11:30a.m. PT/2:30p.m. ETAn audiocast...

Continue reading

MicroVision Announces $10 Million At-the-Market Equity Facility

REDMOND, Wash., Nov. 09, 2020 (GLOBE NEWSWIRE) — MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display technology, today announced it entered into a $10 million At-the-Market (ATM) equity offering agreement with Craig-Hallum Capital Group on November 9, 2020.Under the agreement MicroVision may, from time to time, at its discretion offer and sell shares of its common stock having an aggregate value of up to $10 million through Craig-Hallum. MicroVision intends to use the net proceeds from the ATM, if any, for general corporate purposes, which may include, but are not limited to, working capital and capital expenditures as MicroVision pursues a potential strategic transaction.Under the ATM equity offering sales agreement, sales of common stock, if any, through Craig-Hallum, will be made by means...

Continue reading

Psychemedics Announces Third Quarter Results

ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.The Company’s revenue for the quarter ended September 30, 2020 was $5.2 million versus $9.9 million for the quarter ended September 30, 2019, a decrease of 47%. Net loss for the quarter ended September 30, 2020 was $1.1 million or ($0.20) per diluted share, versus net income of $0.7 million or $0.12 per diluted share, for the comparable period last year. The Company’s revenue for the nine months ended September 30, 2020 was $16.0 million versus $29.0 million for the comparable period in 2019, a decrease of 45%. Net loss for the nine months ended September 30, 2020 was $3.3 million or ($0.60) per diluted share, versus net income of $2.1 million or $0.37 per diluted...

Continue reading

Westport Fuel Systems Announces the Establishment of an At-the-Market Equity Offering Program

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport” or “the Company”) announced today that the Company has established an at-the-market equity offering program (the “ATM Program”) that allows the Company to issue up to US$50 million (or the equivalent in Canadian dollars) of common shares (“Common Shares”)  from treasury to the public from time to time, at the Company’s discretion and subject to regulatory requirements. Any Common Shares sold through the ATM Program will be sold at prevailing market prices when issued (i) in ordinary brokers’ transactions on the Nasdaq Global Select Market (“Nasdaq”) or another U.S. marketplace on which the Common Shares are listed, quoted or otherwise traded or (ii) in ordinary brokers’...

Continue reading

Relay Medical Subsidiary Signs Binding LOI for Rights to COVID-19 Rapid Antigen and Antibody Tests

TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, announces that it has entered into a binding letter of intent (the “Letter of Intent”) with Proprietary Innovation Labs Inc. (“PIL”) relating to the exclusive sale and distribution of rapid diagnostic tests for COVID-19 (the “Products”). The binding LOI was signed November 9, 2020.Under the terms of the LOI agreement Relay Medical’s diagnostics subsidiary, HemoPalm Corp. will acquire the exclusive global rights excluding China to Proprietary Innovation Labs’ COVID-19 product line including CE approved antibody and antigen lateral flow rapid diagnostic tests (RDT).PIL has developed both antigen and antibody tests for the SARS-CoV-2 virus with its manufacturing partners....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.